B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• promote awareness about the importance <strong>of</strong> humor in<br />
maintaining good health and combating stress<br />
• identify tools and practices which can provide humor in one’s<br />
life<br />
• demonstrate an attitude <strong>of</strong> creativity and fun in healthcare<br />
and in everyday settings<br />
InnoVAtion Theater<br />
10:00 - 10:45 am<br />
Halls A1 & A2 (Booth #555)<br />
The following non-CME activity has been planned and will be<br />
implemented in accordance with the requirements <strong>of</strong> the FDA<br />
and applicable standards <strong>of</strong> the PhRMA Code on Interactions<br />
with Healthcare Pr<strong>of</strong>essionals by Forest Pharmaceuticals.<br />
Please visit the Forest Pharmaceuticals exhibit booth for more<br />
information or see page 292. Seating and light refreshments are<br />
subject to availability.<br />
A Treatment Option for the Management <strong>of</strong><br />
Fibromyalgia<br />
ACR Workshops<br />
10:30 - 12:30 pm<br />
Admission to each Workshop requires a separate registration<br />
and ticket. To verify which session you registered for, check to<br />
make sure the registration code on your ticket matches the code<br />
listed below in parentheses.<br />
B201<br />
Designing a Web Site for Your Practice (205)<br />
Speaker: Peter J. Embi, MD, MS; University <strong>of</strong> Cincinnati;<br />
Cincinnati, OH<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• discuss the basics <strong>of</strong> creating Web sites on the internet<br />
• describe how to secure a Web address or domain name for a<br />
practice Web site<br />
• design a basic Web site using online or PC-based tools<br />
B204<br />
Osteoporosis: Interpreting Dual Energy X-ray<br />
Absorptiometry and Clinical Risk Factors: The New<br />
Fracture Risk Assessment Algorithm (206) PS<br />
Speaker: Stuart L. Silverman, MD; Cedars-Sinai Medical Center,<br />
University <strong>of</strong> California-Los Angeles; Beverly Hills, CA<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• determine how to combine bone mineral density and clinical<br />
risk factors in determination <strong>of</strong> absolute risk<br />
• discuss the concept <strong>of</strong> intervention threshold used in National<br />
Osteoporosis Foundation guidelines<br />
• review International Society for Clinical Densitometry<br />
guidelines for DXA interpretation<br />
• create a report for bone densitometry results<br />
B206<br />
Peripheral Magnetic Resonance Imaging in<br />
<strong>Rheumatology</strong> Practice (207)<br />
Speakers: Philip G. Conaghan, MD, PhD; Chapel Allerton<br />
Hospital; Leeds, United Kingdom<br />
Mikkel Østergaard, MD, PhD, DMSc; Hvidovre University<br />
Hospital; Hvidovre, Denmark<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• discuss the logistics <strong>of</strong> implementation <strong>of</strong> peripheral MRI in<br />
the outpatient setting<br />
• review the merits and pitfalls <strong>of</strong> this technology<br />
B202<br />
Renal Histopathology in Systemic Lupus<br />
Erythematosus and Vasculitis (208)<br />
Speaker: Megan Troxell, MD; Oregon Health & Science<br />
University; Portland, OR<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• identify the pathologic changes that occur in lupus nephritis<br />
• discuss the pathologic basis for the classification <strong>of</strong> lupus<br />
nephritis and how it relates to clinical management<br />
• describe the histological changes in the kidneys <strong>of</strong> patients<br />
with vasculitis<br />
ACR Plenary Session I: Discovery 2010<br />
c/r<br />
11:00 am - 12:30 pm<br />
Hall A3<br />
Moderators: Stanley B. Cohen, MD; <strong>Rheumatology</strong> Associates;<br />
Dallas, TX<br />
E. William St.Clair, MD; Duke University Medical Center; Durham,<br />
NC<br />
11:00 AM<br />
ACR REF Industry Roundtable Awards<br />
11:10 AM<br />
ACR Abstract Presentations Introduction<br />
11:15 AM<br />
620. Platelet C4d Is Associated with All-Cause Mortality in<br />
Patients with Systemic Lupus Erythematosus.<br />
Christine A. McBurney 5 , Amy H. Kao 2 , Abdus Sattar 3 , Apinya<br />
Lertratanakul 6 , Nicole L. Wilson 4 , Rutman Sarah 6 , Barbara Paul 6 ,<br />
Jeannine S. Navratil 6 , Joseph M. Ahearn 1 and Susan Manzi 7 ,<br />
1<br />
Wexford, PA, 2 Allegheny Singer Research Institute, Pittsburgh,<br />
PA, 3 Case Western University, 4 Magee Womens Hospital <strong>of</strong><br />
UPMC, Pittsburgh, PA, 5 University <strong>of</strong> Pittsburgh Medical Center,<br />
Pittsburgh, PA, 6 University <strong>of</strong> Pittsburgh School <strong>of</strong> the Health<br />
Sciences, 7 West Penn Allegheny Health System, Pittsburgh, PA<br />
11:30 AM<br />
621. β2-Glycoprotein Exists in a Distinct Molecular Post-<br />
Translational Oxidative State in the Antiphospholipid<br />
Syndrome: Novel Prognostic Assays and Insights into<br />
Antigenicity.<br />
Yiannis Ioannou 10 , Jing-Yun Zhang 8 , Miao Qi 11 , Gao Lu 12 , Jian<br />
Cheng Qi 11 , De-min Yu 7 , Herman Lau 6 , Allan D. Sturgess 5 ,<br />
Panayiotis Vlachoyiannopoulos 4 , Haralampos M. Moutsopoulos 3 ,<br />
monday<br />
2010 Program Book 33